Literature DB >> 20082846

Loss of let-7 binding sites resulting from truncations of the 3' untranslated region of HMGA2 mRNA in uterine leiomyomas.

Markus Klemke1, Anke Meyer, Maliheh Hashemi Nezhad, Gazanfer Belge, Sabine Bartnitzke, Jörn Bullerdiek.   

Abstract

A subset of uterine leiomyomas (UL) shows chromosomal rearrangements of the region 12q14 approximately q15, leading to an overexpression of the high-mobility group protein A2 gene (HMGA2). Recent studies identified microRNAs of the let-7 family as post-transcriptional regulators of HMGA2. Intragenic chromosomal breakpoints might cause truncated HMGA2 transcripts lacking part of the 3' UTR. The corresponding loss of let-7 complementary sites (LCS) located in the 3' UTR would therefore stabilize HMGA2 mRNA. The aim of this study was to check UL with rearrangements of the chromosomal region 12q14 approximately 15 for truncated HMGA2 transcripts by real-time reverse-transcription polymerase chain reaction. In 8/13 leiomyomas with aberrations of chromosomal region 12q15, the results showed the presence of the complete 3' UTR with all LCS. A differential expression with highly reduced 3' untranslated region levels was found in 5/13 myomas. In two of these, full-length transcripts were almost undetectable. Truncated transcripts were apparently predominant in roughly one-third of UL with chromosomal rearrangements affecting the HMGA2 locus, where they lead to a higher stability of its transcripts and subsequently contribute to the overexpression of the protein. The assay used is also generally suited to detect submicroscopic alterations leading to truncated transcripts of HMGA2. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082846     DOI: 10.1016/j.cancergencyto.2009.09.021

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

Review 1.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

Review 2.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

Review 3.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

4.  High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer.

Authors:  Ohuod Hawsawi; Veronica Henderson; Liza J Burton; Jodi Dougan; Peri Nagappan; Valerie Odero-Marah
Journal:  Biochem Biophys Res Commun       Date:  2018-09-01       Impact factor: 3.575

5.  Functional microRNA involved in endometriosis.

Authors:  Shannon M Hawkins; Chad J Creighton; Derek Y Han; Azam Zariff; Matthew L Anderson; Preethi H Gunaratne; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-03-24

6.  Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Hanne Regine Hognestad; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

7.  Fusion of High Mobility Group AT-hook 2 Gene (HMGA2) With the Chromosome 12 Open Reading Frame 42 Gene (C12orf42) in an Aggressive Angiomyxoma With del(12)(q14q23) as the Sole Cytogenetic Anomaly.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

8.  Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.

Authors:  Jeanine D'Armiento; Takayuki Shiomi; Sarah Marks; Patrick Geraghty; Devipriya Sankarasharma; Kiran Chada
Journal:  Cancer Res       Date:  2016-02-02       Impact factor: 12.701

9.  Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Authors:  Martin G Dalin; Nora Katabi; Marta Persson; Ken-Wing Lee; Vladimir Makarov; Alexis Desrichard; Logan A Walsh; Lyndsay West; Zaineb Nadeem; Deepa Ramaswami; Jonathan J Havel; Fengshen Kuo; Kalyani Chadalavada; Gouri J Nanjangud; Ian Ganly; Nadeem Riaz; Alan L Ho; Cristina R Antonescu; Ronald Ghossein; Göran Stenman; Timothy A Chan; Luc G T Morris
Journal:  Nat Commun       Date:  2017-10-30       Impact factor: 14.919

10.  Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.

Authors:  Martin Fritsch; Nicole Schmidt; Ina Gröticke; Anna-Lena Frisk; Christopher S Keator; Markus Koch; Ov D Slayden
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.